Cargando…
Can the development of lung fibrosis be prevented after COVID-19 infection?
Autores principales: | Kalemci, Serdar, Zeybek, Arife, Kargi, Ahmet Bulent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290400/ https://www.ncbi.nlm.nih.gov/pubmed/35891991 http://dx.doi.org/10.5114/kitp.2022.117505 |
Ejemplares similares
-
Acute pulmonary embolism in COVID-19 disease
por: Kalemci, Serdar, et al.
Publicado: (2020) -
Does low levels of vitamin D only show the severity of the disease in children with asthma?
por: Kalemci, Serdar, et al.
Publicado: (2020) -
Bucillamine-induced Pneumonitis in a Patient with Rheumatoid Arthritis-associated Interstitial Pneumonia: A Case Report and Review of the Literature
por: Kalemci, Serdar, et al.
Publicado: (2019) -
Prognostic role of traditional cardiovascular risk factors in patients with idiopathic pulmonary arterial hypertension
por: Kalemci, Serdar, et al.
Publicado: (2019) -
Comment to “Bronchial asthma control degree and the temperament structure according to the Eysenck model”
por: Kalemci, Serdar, et al.
Publicado: (2021)